Tatton Consulting supported Birmingham-based pharmaceutical formulation company Mesox in its successful application to Flexible, agile, scalable medicine manufacturing, awarded £542,014 by Innovate UK for the project A model-based scalable and cost-effective process platform to facilitate the manufacture of complex long-acting injectable (LAI) microspheres.
About the funded R&D project
Long-acting injectables can transform treatment adherence, and most research has gone into new active ingredients rather than into how these products are manufactured. Release profile turns out to be sensitive to manufacturing process, so a formulation that works in the lab can behave differently at production scale. This project develops a model-based process platform to make that relationship predictable.
Award details
- Total project grant: £542,014
- Of which to Mesox: £363,925
- Competition: Flexible, agile, scalable medicine manufacturing
- Competition year: 2023/24
- Project: A model-based scalable and cost-effective process platform to facilitate the manufacture of complex long-acting injectable (LAI) microspheres
- Sector: Pharmaceutical manufacturing
- UKRI project record: Gateway to Research, project 10105165
- Dataset: Innovate UK funded projects, published 10 August 2026
Tatton Consulting supported the competitive grant application. The award value, competition and project title are taken from UKRI’s published record for this project.
See all Innovate UK awards Tatton Consulting has supported on our grant successes page.
